Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
- Status
- COMPLETED
- Phase
- N/A
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Whole Body PET-MRI in Paediatric and Adolescent Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors
- Status
- UNKNOWN
- Phase
- PHASE4
A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib Rollover Study
- Status
- COMPLETED
- Phase
- PHASE2
PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
- Status
- UNKNOWN
- Phase
- PHASE2